Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MEDIRA
Balingen, Baden-Württemberg, Germanymedira.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
MEDIRA is a private German medical technology company developing cardiovascular implants for structural heart disease. The company focuses on minimally invasive and catheter-based solutions intended to make treatment of complex heart and aortic conditions easier, safer, and faster for physicians. Its disclosed lead program, BREVA, is an endovascular stent graft and catheter-based aortic valve prosthesis combination for acute Type A aortic dissection using an "Endo-Bentall" concept. MEDIRA also appears to have intellectual property related to prosthetic valve devices for mitral valve insufficiency. The company is based in Balingen, Germany and is led by founder and CEO Thomas J. Bogenschütz.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceBiologic
- Industry
- Implantable Medical Devices
Beyond the preview
Go deeper on MEDIRA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MEDIRA.